The therapeutic market of leukemia is expected to grow at a CAGR of 3.84% from 2015 to 2020. The market was dominated by drugs such as Gleevec, Hyper-CVAD regimen, Campath, and Sprycel in 2010. However, by 2020; the market is expected to be dominated by GA101/RG7159 (Roche/Biogen Idec), a third-generation, humanized, and glyco-engineered anti-CD20 monoclonal antibody drug; followed by Bosutinib (Pfizer) and Quizartinib (Ambit Bioscience). Pipeline drugs and increasing leukemia population on the global level are the major factors driving the market for new drugs. A potential limiting factor in the growth of sales for leukemia drugs will be the major drugs going off-patent during the time period being forecasted.

From a regional approach, North America accounts for largest leukemia population globally. The incidence rate and mortality rate for leukemia is showing upward trend due to the increase in the aging population in most of the developed countries. Such an upward incidence trend can be attributed to the age risk factor of leukemia. Males and females above 65 years of age are at high risk for leukemia. Among all the cancers, leukemia accounts for about one-third of deaths in children below 15 years of age.

Major players in the market include F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (U.K.), Novartis International AG (Switzerland), Bristol-Myers Squibb (U.S.), Eisai Co. Ltd (Japan), Biogen Idec (U.S.), ERYtech Pharma (France) Celgene Corporation (U.S.), Genmab A/S (Denmark), Cephalon Inc. (U.S.), Clavis Pharma (Norway), and Pfizer Inc. (U.S).

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com

Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your registration.